ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Drug for Therapeutic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-29Y14109
Home | Market Reports | Health| Pharmacy
Global Nuclear Drug for Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Nuclear Drug for Therapeutic Market Research Report 2025

Code: QYRE-Auto-29Y14109
Report
July 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Lantheus
International Isotopes
Jubilant Radiopharma
Aurobindo Pharma
Mundipharma

Nuclear Drug for Therapeutic Market Size

The global market for Nuclear Drug for Therapeutic was valued at US$ 2313 million in the year 2024 and is projected to reach a revised size of US$ 6108 million by 2031, growing at a CAGR of 15.1% during the forecast period.

Nuclear Drug for Therapeutic Market

Nuclear Drug for Therapeutic Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nuclear Drug for Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Drug for Therapeutic.
The Nuclear Drug for Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Drug for Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Drug for Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nuclear Drug for Therapeutic Market Report

Report Metric Details
Report Name Nuclear Drug for Therapeutic Market
Accounted market size in year US$ 2313 million
Forecasted market size in 2031 US$ 6108 million
CAGR 15.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Segment by Application
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nuclear Drug for Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nuclear Drug for Therapeutic Market growing?

Ans: The Nuclear Drug for Therapeutic Market witnessing a CAGR of 15.1% during the forecast period 2025-2031.

What is the Nuclear Drug for Therapeutic Market size in 2031?

Ans: The Nuclear Drug for Therapeutic Market size in 2031 will be US$ 6108 million.

Who are the main players in the Nuclear Drug for Therapeutic Market report?

Ans: The main players in the Nuclear Drug for Therapeutic Market are Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma

What are the Application segmentation covered in the Nuclear Drug for Therapeutic Market report?

Ans: The Applications covered in the Nuclear Drug for Therapeutic Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Nuclear Drug for Therapeutic Market report?

Ans: The Types covered in the Nuclear Drug for Therapeutic Market report are Radium-223, Lutetium-177, Iodine-131, Other

Recommended Reports

Therapeutic Radiopharmaceuticals

Radiation Oncology Devices

Oncology Diagnostics & Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nuclear Drug for Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Drug for Therapeutic Market Perspective (2020-2031)
2.2 Global Nuclear Drug for Therapeutic Growth Trends by Region
2.2.1 Global Nuclear Drug for Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Drug for Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Drug for Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Drug for Therapeutic Market Dynamics
2.3.1 Nuclear Drug for Therapeutic Industry Trends
2.3.2 Nuclear Drug for Therapeutic Market Drivers
2.3.3 Nuclear Drug for Therapeutic Market Challenges
2.3.4 Nuclear Drug for Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Drug for Therapeutic Players by Revenue
3.1.1 Global Top Nuclear Drug for Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Drug for Therapeutic Revenue
3.4 Global Nuclear Drug for Therapeutic Market Concentration Ratio
3.4.1 Global Nuclear Drug for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Drug for Therapeutic Revenue in 2024
3.5 Global Key Players of Nuclear Drug for Therapeutic Head office and Area Served
3.6 Global Key Players of Nuclear Drug for Therapeutic, Product and Application
3.7 Global Key Players of Nuclear Drug for Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Drug for Therapeutic Breakdown Data by Type
4.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2026-2031)
5 Nuclear Drug for Therapeutic Breakdown Data by Application
5.1 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Drug for Therapeutic Market Size (2020-2031)
6.2 North America Nuclear Drug for Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Drug for Therapeutic Market Size by Country (2020-2025)
6.4 North America Nuclear Drug for Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Drug for Therapeutic Market Size (2020-2031)
7.2 Europe Nuclear Drug for Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Drug for Therapeutic Market Size by Country (2020-2025)
7.4 Europe Nuclear Drug for Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Drug for Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Drug for Therapeutic Market Size (2020-2031)
9.2 Latin America Nuclear Drug for Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Drug for Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Nuclear Drug for Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Drug for Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Nuclear Drug for Therapeutic Introduction
11.1.4 Bayer Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Nuclear Drug for Therapeutic Introduction
11.2.4 Novartis Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Details
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Introduction
11.3.4 China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Company Details
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Nuclear Drug for Therapeutic Introduction
11.4.4 Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Company Details
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Nuclear Drug for Therapeutic Introduction
11.5.4 Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Details
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Introduction
11.6.4 Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Details
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Introduction
11.7.4 Jubilant Radiopharma Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.7.5 Jubilant Radiopharma Recent Development
11.8 Lantheus
11.8.1 Lantheus Company Details
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Nuclear Drug for Therapeutic Introduction
11.8.4 Lantheus Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.8.5 Lantheus Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Details
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Introduction
11.9.4 Aurobindo Pharma Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.9.5 Aurobindo Pharma Recent Development
11.10 International Isotopes
11.10.1 International Isotopes Company Details
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Nuclear Drug for Therapeutic Introduction
11.10.4 International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.10.5 International Isotopes Recent Development
11.11 Mundipharma
11.11.1 Mundipharma Company Details
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Nuclear Drug for Therapeutic Introduction
11.11.4 Mundipharma Revenue in Nuclear Drug for Therapeutic Business (2020-2025)
11.11.5 Mundipharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Lantheus
International Isotopes
Jubilant Radiopharma
Aurobindo Pharma
Mundipharma
List of Tables
 Table 1. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Radium-223
 Table 3. Key Players of Lutetium-177
 Table 4. Key Players of Iodine-131
 Table 5. Key Players of Other
 Table 6. Global Nuclear Drug for Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Nuclear Drug for Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Nuclear Drug for Therapeutic Market Share by Region (2020-2025)
 Table 10. Global Nuclear Drug for Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Nuclear Drug for Therapeutic Market Share by Region (2026-2031)
 Table 12. Nuclear Drug for Therapeutic Market Trends
 Table 13. Nuclear Drug for Therapeutic Market Drivers
 Table 14. Nuclear Drug for Therapeutic Market Challenges
 Table 15. Nuclear Drug for Therapeutic Market Restraints
 Table 16. Global Nuclear Drug for Therapeutic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Nuclear Drug for Therapeutic Market Share by Players (2020-2025)
 Table 18. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2024)
 Table 19. Ranking of Global Top Nuclear Drug for Therapeutic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Nuclear Drug for Therapeutic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Nuclear Drug for Therapeutic, Headquarters and Area Served
 Table 22. Global Key Players of Nuclear Drug for Therapeutic, Product and Application
 Table 23. Global Key Players of Nuclear Drug for Therapeutic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Nuclear Drug for Therapeutic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2020-2025)
 Table 27. Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2026-2031)
 Table 29. Global Nuclear Drug for Therapeutic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2020-2025)
 Table 31. Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2026-2031)
 Table 33. North America Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Nuclear Drug for Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Nuclear Drug for Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Nuclear Drug for Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nuclear Drug for Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Bayer Company Details
 Table 49. Bayer Business Overview
 Table 50. Bayer Nuclear Drug for Therapeutic Product
 Table 51. Bayer Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 52. Bayer Recent Development
 Table 53. Novartis Company Details
 Table 54. Novartis Business Overview
 Table 55. Novartis Nuclear Drug for Therapeutic Product
 Table 56. Novartis Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 57. Novartis Recent Development
 Table 58. China Isotope & Radiation Company Details
 Table 59. China Isotope & Radiation Business Overview
 Table 60. China Isotope & Radiation Nuclear Drug for Therapeutic Product
 Table 61. China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 62. China Isotope & Radiation Recent Development
 Table 63. Dongcheng Company Details
 Table 64. Dongcheng Business Overview
 Table 65. Dongcheng Nuclear Drug for Therapeutic Product
 Table 66. Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 67. Dongcheng Recent Development
 Table 68. Q BioMed Company Details
 Table 69. Q BioMed Business Overview
 Table 70. Q BioMed Nuclear Drug for Therapeutic Product
 Table 71. Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 72. Q BioMed Recent Development
 Table 73. Curium Pharmaceuticals Company Details
 Table 74. Curium Pharmaceuticals Business Overview
 Table 75. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product
 Table 76. Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 77. Curium Pharmaceuticals Recent Development
 Table 78. Jubilant Radiopharma Company Details
 Table 79. Jubilant Radiopharma Business Overview
 Table 80. Jubilant Radiopharma Nuclear Drug for Therapeutic Product
 Table 81. Jubilant Radiopharma Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 82. Jubilant Radiopharma Recent Development
 Table 83. Lantheus Company Details
 Table 84. Lantheus Business Overview
 Table 85. Lantheus Nuclear Drug for Therapeutic Product
 Table 86. Lantheus Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 87. Lantheus Recent Development
 Table 88. Aurobindo Pharma Company Details
 Table 89. Aurobindo Pharma Business Overview
 Table 90. Aurobindo Pharma Nuclear Drug for Therapeutic Product
 Table 91. Aurobindo Pharma Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 92. Aurobindo Pharma Recent Development
 Table 93. International Isotopes Company Details
 Table 94. International Isotopes Business Overview
 Table 95. International Isotopes Nuclear Drug for Therapeutic Product
 Table 96. International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 97. International Isotopes Recent Development
 Table 98. Mundipharma Company Details
 Table 99. Mundipharma Business Overview
 Table 100. Mundipharma Nuclear Drug for Therapeutic Product
 Table 101. Mundipharma Revenue in Nuclear Drug for Therapeutic Business (2020-2025) & (US$ Million)
 Table 102. Mundipharma Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Nuclear Drug for Therapeutic Picture
 Figure 2. Global Nuclear Drug for Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nuclear Drug for Therapeutic Market Share by Type: 2024 VS 2031
 Figure 4. Radium-223 Features
 Figure 5. Lutetium-177 Features
 Figure 6. Iodine-131 Features
 Figure 7. Other Features
 Figure 8. Global Nuclear Drug for Therapeutic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Nuclear Drug for Therapeutic Market Share by Application: 2024 VS 2031
 Figure 10. Thyroid Case Studies
 Figure 11. Bone Metastasis Case Studies
 Figure 12. Lymphoma Case Studies
 Figure 13. Other Case Studies
 Figure 14. Nuclear Drug for Therapeutic Report Years Considered
 Figure 15. Global Nuclear Drug for Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Nuclear Drug for Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Nuclear Drug for Therapeutic Market Share by Region: 2024 VS 2031
 Figure 18. Global Nuclear Drug for Therapeutic Market Share by Players in 2024
 Figure 19. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Nuclear Drug for Therapeutic Revenue in 2024
 Figure 21. North America Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Nuclear Drug for Therapeutic Market Share by Country (2020-2031)
 Figure 23. United States Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Nuclear Drug for Therapeutic Market Share by Country (2020-2031)
 Figure 27. Germany Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2020-2031)
 Figure 35. China Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Nuclear Drug for Therapeutic Market Share by Country (2020-2031)
 Figure 43. Mexico Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Country (2020-2031)
 Figure 47. Turkey Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Nuclear Drug for Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Bayer Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 52. China Isotope & Radiation Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 53. Dongcheng Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 54. Q BioMed Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 55. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 56. Jubilant Radiopharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 57. Lantheus Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 58. Aurobindo Pharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 59. International Isotopes Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 60. Mundipharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Therapeutic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiopharmaceuticals for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Nuclear Medicines Market Insights Forecast to 2030
Global Radioactive Therapeutic Drugs Market Research Report 2024
Global Therapeutic Radioisotopes Market Insights Forecast to 2030
Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030
Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Medicine Market Research Report 2025
Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030
Diagnostic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical Therapy Market Research Report 2025
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Radiopharmaceutical Market Research Report 2025
Global Radioisotopes in Medicine Market Research Report 2025
Global SPECT and PET Radiopharmaceuticals Market Research Report 2024
Global Targeted Radionuclide Therapy Market Research Report 2024
Global Medical Radioisotopes Market Research Report 2025
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions